Dechra Pharmaceuticals PLC Holding(s) in Company (8748Z)
16 Enero 2024 - 6:04AM
UK Regulatory
TIDMDPH TIDMBARC
RNS Number : 8748Z
Dechra Pharmaceuticals PLC
16 January 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0009633180
Issuer Name
DECHRA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Barclays PLC
City of registered office (if applicable)
London
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Name City of registered office Country of registered office
Barclays Capital Securities Limited London United Kingdom
=========================== ==============================
5. Date on which the threshold was crossed or reached
12-Jan-2024
6. Date on which Issuer notified
16-Jan-2024
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 5.430000 0.480000 5.910000 6730238
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 5.970000 0.570000 6.540000
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB0009633180 6180599 5.430000
====================== ====================== ====================== ======================
Sub Total 8.A 6180599 5.430000%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Portfolio Swap n/a n/a Cash 549639 0.480000
================ ==================== ================== ================== ==================
Sub Total 8.B2 549639 0.480000%
================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
Barclays Capital
Barclays PLC Securities Limited 5.430000 5.910000%
======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Full chain of controlled undertaking:
Barclays PLC
Barclays Bank PLC (100%)
Barclays Capital Securities Limited(100%)
12. Date of Completion
16-Jan-2024
13. Place Of Completion
London
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUNRURSOUAAAR
(END) Dow Jones Newswires
January 16, 2024 07:04 ET (12:04 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
